These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 25072151)

  • 61. Interaction between antimicrobial peptides and mycobacteria.
    Gutsmann T
    Biochim Biophys Acta; 2016 May; 1858(5):1034-43. PubMed ID: 26851776
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Structure-Activity Relationships of a Diverse Class of Halogenated Phenazines That Targets Persistent, Antibiotic-Tolerant Bacterial Biofilms and Mycobacterium tuberculosis.
    Garrison AT; Abouelhassan Y; Norwood VM; Kallifidas D; Bai F; Nguyen MT; Rolfe M; Burch GM; Jin S; Luesch H; Huigens RW
    J Med Chem; 2016 Apr; 59(8):3808-25. PubMed ID: 27018907
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Bacterial Biofilm Eradication Agents: A Current Review.
    Verderosa AD; Totsika M; Fairfull-Smith KE
    Front Chem; 2019; 7():824. PubMed ID: 31850313
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Investigation of extracellular polymeric substances (EPS) properties of P. aeruginosa and B. subtilis and their role in bacterial adhesion.
    Harimawan A; Ting YP
    Colloids Surf B Biointerfaces; 2016 Oct; 146():459-67. PubMed ID: 27395039
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Recent perspectives on the molecular basis of biofilm formation by Pseudomonas aeruginosa and approaches for treatment and biofilm dispersal.
    Skariyachan S; Sridhar VS; Packirisamy S; Kumargowda ST; Challapilli SB
    Folia Microbiol (Praha); 2018 Jul; 63(4):413-432. PubMed ID: 29352409
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Biofilm--"City of microbes" or an analogue of multicellular organisms?].
    Nikolaev IuA; Plakunov VK
    Mikrobiologiia; 2007; 76(2):149-63. PubMed ID: 17583210
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Living in the matrix: assembly and control of Vibrio cholerae biofilms.
    Teschler JK; Zamorano-Sánchez D; Utada AS; Warner CJ; Wong GC; Linington RG; Yildiz FH
    Nat Rev Microbiol; 2015 May; 13(5):255-68. PubMed ID: 25895940
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Carbonic Anhydrase Inhibitors as Novel Drugs against Mycobacterial β-Carbonic Anhydrases: An Update on
    Aspatwar A; Winum JY; Carta F; Supuran CT; Hammaren M; Parikka M; Parkkila S
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30413024
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Rapid adaptation of a complex trait during experimental evolution of
    Smith TM; Youngblom MA; Kernien JF; Mohamed MA; Fry SS; Bohr LL; Mortimer TD; O'Neill MB; Pepperell CS
    Elife; 2022 Jun; 11():. PubMed ID: 35726854
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Biofilms: The Microbial "Protective Clothing" in Extreme Environments.
    Yin W; Wang Y; Liu L; He J
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336824
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Silver nanoparticles as an alternative strategy against bacterial biofilms.
    Markowska K; Grudniak AM; Wolska KI
    Acta Biochim Pol; 2013; 60(4):523-30. PubMed ID: 24432308
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Regulatory mechanism underlying pathogen biofilm formation and potential drug targets].
    Shi TY; Deng WY; Xie JP
    Yao Xue Xue Bao; 2012 Feb; 47(2):135-43. PubMed ID: 22512022
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dynamic Dispersal of Surface Layer Biofilm Induced by Nanosized TiO
    Zhang P; Guo JS; Yan P; Chen YP; Wang W; Dai YZ; Fang F; Wang GX; Shen Y
    Appl Environ Microbiol; 2018 May; 84(9):. PubMed ID: 29500260
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Accelerating Early Antituberculosis Drug Discovery by Creating Mycobacterial Indicator Strains That Predict Mode of Action.
    Boot M; Commandeur S; Subudhi AK; Bahira M; Smith TC; Abdallah AM; van Gemert M; Lelièvre J; Ballell L; Aldridge BB; Pain A; Speer A; Bitter W
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29661879
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Biofilms--a microbial life perspective: a critical review.
    Jain A; Gupta Y; Agrawal R; Khare P; Jain SK
    Crit Rev Ther Drug Carrier Syst; 2007; 24(5):393-443. PubMed ID: 18197780
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mycobacterial DNA Replication as a Target for Antituberculosis Drug Discovery.
    Płocinska R; Korycka-Machala M; Plocinski P; Dziadek J
    Curr Top Med Chem; 2017 Jun; 17(19):2129-2142. PubMed ID: 28137234
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Adhesion forces of biofilms developed in vitro from clinical strains of skin wounds.
    Alvarado-Gomez E; Perez-Diaz M; Valdez-Perez D; Ruiz-Garcia J; Magaña-Aquino M; Martinez-Castañon G; Martinez-Gutierrez F
    Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():336-344. PubMed ID: 29025667
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Bacterial biofilms within the clinical setting: what healthcare professionals should know.
    Lindsay D; von Holy A
    J Hosp Infect; 2006 Dec; 64(4):313-25. PubMed ID: 17046102
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Adherence and biofilm formation of Staphylococcus epidermidis and Mycobacterium tuberculosis on various spinal implants.
    Ha KY; Chung YG; Ryoo SJ
    Spine (Phila Pa 1976); 2005 Jan; 30(1):38-43. PubMed ID: 15626979
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Drug targets in mycobacterial sulfur metabolism.
    Bhave DP; Muse WB; Carroll KS
    Infect Disord Drug Targets; 2007 Jun; 7(2):140-58. PubMed ID: 17970225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.